An epidemiological framework for improving the accuracy of whole-genome sequence-based antimicrobial resistance surveillance in Salmonella
Canadian Journal of Microbiology · 2025
DOI: 10.1139/cjm-2024-0090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Microbiology, 2025. Verfasst von Benjamin M Hetman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada. Hauptthemen laut MEDLINE: Whole Genome Sequencing, Salmonella, Genome, Bacterial, Drug Resistance, Bacterial. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Genomic Research and Development Initiative on Antimicrobial Resistance, Ontario Veterinary College.
Abstract (Originalsprache)
Whole-genome sequence-based surveillance of bacteria for determinants of antimicrobial resistance (AMR) promises many advantages over traditional, wet-lab approaches. However, adjustments to parameters used to identify genetic determinants from sequencing data can affect results and interpretation of the important determinants in circulation. Using a dataset of whole-genome sequences from 1633 isolates of Salmonella Heidelberg and S. Kentucky collected from surveillance of Canadian poultry production, we queried the genomic data using an in silico AMR detection tool, StarAMR, applying a range of parameter values required for the detection pipeline to test for differences in detection accuracy. We compared the results from each iteration to phenotypic antimicrobial susceptibility results, and generated estimates of sensitivity and specificity using regression models that controlled for the effects of multiple sampling events and variables, and interactions between covariates. Results from our analyses revealed small, yet significant effects of the input parameters on the sensitivity and specificity of the AMR detection tool, and these effects differed based on the serovar and drug class in question. Findings from this study may have implications for the incorporation of whole-genome sequence-based approaches to the surveillance of AMR determinants in bacteria sampled from food products and animals related to food production.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada.
- Office of Public Health Field Services and Training, Center for Emergency Preparedness, Public Health Agency of Canada, Winnipeg, MB, Canada.
- Centre for Foodborne, Environmental and Zoonotic Infectious Diseases, Public Health Agency of Canada, Guelph, ON, Canada.
- National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.
- Department of Food and Human Nutritional Sciences, University of Manitoba, Winnipeg, MB, Canada.
ORCID-Profile: Benjamin M Hetman
Förderung
- Genomic Research and Development Initiative on Antimicrobial Resistance
- Ontario Veterinary College
Zitieren
APA
Hetman, B. M., Pearl, D., Reid-Smith, R., Parmley, E., & Taboada, E. (2025). An epidemiological framework for improving the accuracy of whole-genome sequence-based antimicrobial resistance surveillance in Salmonella. Canadian Journal of Microbiology. https://doi.org/10.1139/cjm-2024-0090
Vancouver
Hetman BM, Pearl D, Reid-Smith R, Parmley E, Taboada E. An epidemiological framework for improving the accuracy of whole-genome sequence-based antimicrobial resistance surveillance in Salmonella. Canadian Journal of Microbiology. 2025. doi:10.1139/cjm-2024-0090
BibTeX
@article{Hetman2025,
author = {Hetman, Benjamin M and Pearl, David L and Reid-Smith, Richard and Parmley, E Jane and Taboada, Eduardo N},
title = {An epidemiological framework for improving the accuracy of whole-genome sequence-based antimicrobial resistance surveillance in Salmonella},
journal = {Canadian Journal of Microbiology},
year = {2025},
doi = {10.1139/cjm-2024-0090}
}
EUVIMED